Mary Morrow

机构：University of Colorado Anschutz Medical Campus · ORCID：0000-0002-2115-4864

发表论文 41 篇 · 总被引 950 次 · h-index 16

代表论文

• Safety, feasibility and initial efficacy of an app-facilitated telerehabilitation (AFTER) programme for COVID-19 survivors: a pilot randomised study (2022 · BMJ Open · 被引 64)
• Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study (2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 57)
• Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate (2021 · AIDS · 被引 31)
• Postacute Sequelae of SARS-CoV-2 Infection and Impact on Quality of Life 1–6 Months After Illness and Association With Initial Symptom Severity (2021 · Open Forum Infectious Diseases · 被引 29)
• Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV (2021 · Open Forum Infectious Diseases · 被引 28)
• Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV (2020 · Journal of Antimicrobial Chemotherapy · 被引 22)